ArticleInternational urology and nephrology2009
Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis.
Article in International urology and nephrology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.World journal of surgery · 2022Pooled it
- A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.International urology and nephrology · 2022Pooled it
- Vascular Involvement in Emphysematous Pyelonephritis.Case reports in urology · 2026Article
- Analysis of Pathogenic Bacteria, Drug Resistance and Treatment of Emphysematous Pyelonephritis: A Case Series.Infection and drug resistance · 2026Article
- Emphysematous Urinary Tract Infections in Regional Australia: Retrospective Review of Risk Factors, Microbiology, Management and Outcomes from 38 Cases.Research and reports in urology · 2026Article
- Morphological transition after medical treatment of emphysematous pyelonephritis over time-case report.BMC nephrology · 2025Article
- Scoring System to Personalize Management of Emphysematous Pyelonephritis.Urology research & practice · 2024Article
- A novel mortality risk score for emphysematous pyelonephritis: A multicenter study of the Global Research in the Emphysematous Pyelonephritis group.Current urology · 2024Article
- Report on the diagnosis and treatment of 3 cases of emphysematous pyelonephritis with two different outcomes.Frontiers in medicine · 2024Article
- Risk factors for sepsis and mortality in patients with emphysematous pyelonephritis : a series of 68 cases (case series).Annals of medicine and surgery (2012) · 2024Article
- Conservative Management of a COVID-19-positive Patient With Emphysematous Pyelonephritis: A Case Report.Cureus · 2023Article
- Performance of Scoring Systems in Predicting Clinical Outcomes of Patients with Emphysematous Pyelonephritis: A 14-Year Hospital-Based Study.Journal of clinical medicine · 2022Article
- Bilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report.The American journal of case reports · 2022Article
- Emphysematous pyelonephritis caused by candida species: A case report and outcome of 1 year follow-up.Urology case reports · 2020Article
- Emphysematous pyelonephritis treatment strategies in correlation to the CT classification: have the current experience and prognosis changed?International urology and nephrology · 2019Article
- Emphysematous Pyelonephritis Case Series From South India.Kidney international reports · 2018Article
- Emphysematous pyelonephritis and cystitis: A case report and literature review.The Journal of international medical research · 2018Review
- Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy?International urology and nephrology · 2017Article
- Observational
- Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis.BMC infectious diseases · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimWe aimed to study the clinical profile, prognostic factors, and the 6-month outcome of patients with emphysematous pyelonephritis (EPN)
methodsAll patients admitted with a diagnosis of emphysematous pyelonephritis between January 2001 and July 2007 were included.
resultsOverall 19 cases were diagnosed to have emphysematous pyelonephritis. There were 16 females and three males. Fourteen cases had type 2 diabetes mellitus. Fourteen cases had unilateral involvement and five had bilateral involvement. Eleven cases were classified as having class 1 or 2 disease and eight cases had class 3 and 4 disease. E. coli was the most common organism cultured (68.4%). Five cases underwent percutaneous drainage of the collecting system and three cases had nephrectomy of which 10.5% (two with advanced disease) expired. Shock at admission (p = 0.03), serum creatinine >5.0 mg/dl (p = 0.035) and DIC (p = 0.017) were independent poor prognostic factors. There was no difference in the prognosis between patients who had >or=2 or <2 poor prognostic factors (p = 0.16). However, prognosis was not related to disease class, unilateral vs. bilateral involvement, sepsis or the age of the patient. At 6 months, two patients were on maintenance hemodialysis.
conclusionsIn cases of EPN, shock, serum creatinine >5.0 mg/dl and DIC at admission are poor prognostic factors. Larger prospective studies are needed to confirm our findings.
Indexed as
Identifiers
19404766What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.